SI9300140A - N-t-butyl-androst-3,5-diene-17(beta)-carboxamide-3-carboxylic acid polymorph a - Google Patents
N-t-butyl-androst-3,5-diene-17(beta)-carboxamide-3-carboxylic acid polymorph a Download PDFInfo
- Publication number
- SI9300140A SI9300140A SI19939300140A SI9300140A SI9300140A SI 9300140 A SI9300140 A SI 9300140A SI 19939300140 A SI19939300140 A SI 19939300140A SI 9300140 A SI9300140 A SI 9300140A SI 9300140 A SI9300140 A SI 9300140A
- Authority
- SI
- Slovenia
- Prior art keywords
- common
- polymorph
- butyl
- androst
- diene
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 39
- 150000001875 compounds Chemical class 0.000 claims description 17
- 239000000725 suspension Substances 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 9
- 238000002329 infrared spectrum Methods 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000002441 X-ray diffraction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000001665 trituration Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 238000000634 powder X-ray diffraction Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229910000661 Mercury cadmium telluride Inorganic materials 0.000 description 1
- 241001311547 Patina Species 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- MCMSPRNYOJJPIZ-UHFFFAOYSA-N cadmium;mercury;tellurium Chemical compound [Cd]=[Te]=[Hg] MCMSPRNYOJJPIZ-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929206413A GB9206413D0 (en) | 1992-03-24 | 1992-03-24 | N-t-butyl-androst-3,5-diene-17b-carboxamide-3-carboxylic acid polymorph a |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI9300140A true SI9300140A (en) | 1993-09-30 |
Family
ID=10712749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI19939300140A SI9300140A (en) | 1992-03-24 | 1993-03-23 | N-t-butyl-androst-3,5-diene-17(beta)-carboxamide-3-carboxylic acid polymorph a |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0633892B1 (cs) |
| JP (1) | JP2736169B2 (cs) |
| CN (1) | CN1078723A (cs) |
| AP (1) | AP403A (cs) |
| AT (1) | ATE180490T1 (cs) |
| AU (1) | AU669522B2 (cs) |
| BG (1) | BG99062A (cs) |
| BR (1) | BR9306139A (cs) |
| CA (1) | CA2132535A1 (cs) |
| CZ (1) | CZ286266B6 (cs) |
| DE (1) | DE69325094T2 (cs) |
| DK (1) | DK0633892T3 (cs) |
| ES (1) | ES2134260T3 (cs) |
| FI (1) | FI114709B (cs) |
| GB (1) | GB9206413D0 (cs) |
| GR (1) | GR3030779T3 (cs) |
| HU (1) | HUT68120A (cs) |
| IL (1) | IL105102A (cs) |
| MA (1) | MA22841A1 (cs) |
| MX (1) | MX9301656A (cs) |
| NO (1) | NO943547L (cs) |
| NZ (1) | NZ252008A (cs) |
| OA (1) | OA10100A (cs) |
| PL (1) | PL172523B1 (cs) |
| RU (1) | RU94041839A (cs) |
| SI (1) | SI9300140A (cs) |
| SK (1) | SK113894A3 (cs) |
| WO (1) | WO1993019081A1 (cs) |
| ZA (1) | ZA932014B (cs) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
| IL104602A (en) * | 1992-02-07 | 1997-07-13 | Smithkline Beecham Corp | Process for the preparation of 3-carbonylandrostadiene- 17-carboxamides and intermediates for this process |
-
1992
- 1992-03-24 GB GB929206413A patent/GB9206413D0/en active Pending
-
1993
- 1993-03-18 IL IL10510293A patent/IL105102A/xx not_active IP Right Cessation
- 1993-03-18 AP APAP/P/1993/000497A patent/AP403A/en active
- 1993-03-22 ZA ZA932014A patent/ZA932014B/xx unknown
- 1993-03-23 SI SI19939300140A patent/SI9300140A/sl unknown
- 1993-03-23 MA MA23136A patent/MA22841A1/fr unknown
- 1993-03-24 RU RU94041839/04A patent/RU94041839A/ru unknown
- 1993-03-24 AU AU40448/93A patent/AU669522B2/en not_active Ceased
- 1993-03-24 SK SK1138-94A patent/SK113894A3/sk unknown
- 1993-03-24 WO PCT/US1993/002974 patent/WO1993019081A1/en active IP Right Grant
- 1993-03-24 PL PL93305206A patent/PL172523B1/pl unknown
- 1993-03-24 CZ CZ19942319A patent/CZ286266B6/cs not_active IP Right Cessation
- 1993-03-24 CN CN 93103518 patent/CN1078723A/zh active Pending
- 1993-03-24 BR BR9306139A patent/BR9306139A/pt not_active Application Discontinuation
- 1993-03-24 AT AT93911567T patent/ATE180490T1/de not_active IP Right Cessation
- 1993-03-24 MX MX9301656A patent/MX9301656A/es unknown
- 1993-03-24 DK DK93911567T patent/DK0633892T3/da active
- 1993-03-24 EP EP93911567A patent/EP0633892B1/en not_active Expired - Lifetime
- 1993-03-24 HU HU9402740A patent/HUT68120A/hu unknown
- 1993-03-24 NZ NZ252008A patent/NZ252008A/en unknown
- 1993-03-24 ES ES93911567T patent/ES2134260T3/es not_active Expired - Lifetime
- 1993-03-24 JP JP5516858A patent/JP2736169B2/ja not_active Expired - Fee Related
- 1993-03-24 CA CA002132535A patent/CA2132535A1/en not_active Abandoned
- 1993-03-24 DE DE69325094T patent/DE69325094T2/de not_active Expired - Fee Related
-
1994
- 1994-09-20 OA OA60561A patent/OA10100A/en unknown
- 1994-09-23 NO NO943547A patent/NO943547L/no unknown
- 1994-09-23 FI FI944414A patent/FI114709B/fi active
- 1994-09-26 BG BG99062A patent/BG99062A/xx unknown
-
1999
- 1999-07-14 GR GR990401866T patent/GR3030779T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2722496C (en) | Crystalline minocycline base and processes for its preparation | |
| EP0298202B1 (en) | Organic salts of physostigmine derivatives | |
| EP1112280B1 (en) | Method of preparing form ii crystals of clarithromycin | |
| US2997470A (en) | Lysergic acid amides | |
| SK95699A3 (en) | Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1- -ethoxycarbonyl-aminobenzene and processes for preparing said compound | |
| DE60001346T2 (de) | Verfahren zur Herstellung von Form II Kristallen des Clarithromycins | |
| KR20010042078A (ko) | 피리다지논 염산염 화합물 및 그 제조방법 | |
| SK285216B6 (sk) | Spôsob prípravy kryštalickej formy N-(4-trifluórmetylfenyl)-5- metyl-izoxazol-4-karboxamidu | |
| EP0387821B1 (de) | 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel | |
| SI9300140A (en) | N-t-butyl-androst-3,5-diene-17(beta)-carboxamide-3-carboxylic acid polymorph a | |
| CN113549084B (zh) | 一种立体选择性合成手性内酯的方法 | |
| CN105315198A (zh) | 一种吡非尼酮的晶型及其制备方法 | |
| US2776979A (en) | 1-nitroso-2-imidazolidone and process | |
| US5596109A (en) | N-t-butyl-androst-3,5-diene-17β-carboxamide-3-carboxylic acid polymorph A | |
| EA008055B1 (ru) | Кристаллические формы оланзапина и способы их получения | |
| US5859266A (en) | "N-T-butyl-androst-3-5-diene-17 β-carboxamide-3-carboxylic" acid polymorph A | |
| CN113336741A (zh) | 雷贝拉唑钠无水物晶型及其制备方法 | |
| CA1089855A (en) | Derivatives of pyrazolo [1,5-a] pyrido [2,3- d]-pyrimidin-9(4h)-one | |
| US2777856A (en) | Process for chlorinating a basic cyclic guanidine | |
| Ames et al. | 597. Synthesis of some methyl-substituted 2: 3: 6-trihydroxypyridines | |
| Taylor et al. | Synthesis and properties of 7-azaxanthopterin | |
| DE2026057C3 (de) | Verfahren zur Herstellung von Metallphthalocyanin in der X-Form | |
| US3112316A (en) | Z-o-chlohobenzylmercapto-x-dimethyl- | |
| EP3351530B1 (en) | Method of producing a sodium salt of (2,6-dichlorophenyl)amide carbopentoxysulphanilic acid | |
| DE2623417A1 (de) | 1,2,3,4-tetrahydro-4-oxo-(oder -oxy-)-1-naphthylharnstoffe und verfahren zu ihrer herstellung |